135 related articles for article (PubMed ID: 38313233)
1. Leukocyte immunoglobulin-like receptor B2: A promising biomarker for colorectal cancer.
Zhao WZ; Wang HG; Yang XZ
World J Gastroenterol; 2024 Jan; 30(4):421-423. PubMed ID: 38313233
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte immunoglobulin-like receptor B2 overexpression as a promising therapeutic target and noninvasive screening biomarker for colorectal cancer.
Wang QQ; Zhou L; Qin G; Tan C; Zhou YC; Yao SK
World J Gastroenterol; 2023 Oct; 29(37):5313-5326. PubMed ID: 37899785
[TBL] [Abstract][Full Text] [Related]
3. Expression of leukocyte immunoglobulin-like receptor B2 in hepatocellular carcinoma and its clinical significance.
Li X; Wei X; Xu H; Sha Z; Gao A; Sun Y; Li J; Xu L
J Cancer Res Ther; 2018; 14(7):1655-1659. PubMed ID: 30589055
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer.
Chen QY; Chen YX; Han QY; Zhang JG; Zhou WJ; Zhang X; Ye YH; Yan WH; Lin A
Front Immunol; 2021; 12():679090. PubMed ID: 34054869
[TBL] [Abstract][Full Text] [Related]
5. A motif in LILRB2 critical for Angptl2 binding and activation.
Deng M; Lu Z; Zheng J; Wan X; Chen X; Hirayasu K; Sun H; Lam Y; Chen L; Wang Q; Song C; Huang N; Gao GF; Jiang Y; Arase H; Zhang CC
Blood; 2014 Aug; 124(6):924-35. PubMed ID: 24899623
[TBL] [Abstract][Full Text] [Related]
6. ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells.
Liu X; Yu X; Xie J; Zhan M; Yu Z; Xie L; Zeng H; Zhang F; Chen G; Yi X; Zheng J
Oncotarget; 2015 Aug; 6(25):21004-15. PubMed ID: 26056041
[TBL] [Abstract][Full Text] [Related]
7. LILRB2-containing small extracellular vesicles from glioblastoma promote tumor progression by promoting the formation and expansion of myeloid-derived suppressor cells.
Wu P; Guo Y; Xiao L; Yuan J; Tang C; Dong J; Qian Z
Cancer Immunol Immunother; 2023 Jul; 72(7):2179-2193. PubMed ID: 36853330
[TBL] [Abstract][Full Text] [Related]
8. LILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis.
Li DP; Huang L; Kan RR; Meng XY; Wang SY; Zou HJ; Guo YM; Luo PQ; Pan LM; Xiang YX; Mao BB; Xie YY; Wang ZH; Yang M; He R; Yang Y; Liu ZL; Xie JH; Ma DL; Zhang BP; Shao SY; Chen X; Xu SM; He WT; Li WJ; Chen Y; Yu XF
Nat Commun; 2023 Jul; 14(1):4436. PubMed ID: 37481670
[TBL] [Abstract][Full Text] [Related]
9. An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis.
Carbone C; Piro G; Fassan M; Tamburrino A; Mina MM; Zanotto M; Chiao PJ; Bassi C; Scarpa A; Tortora G; Melisi D
Oncotarget; 2015 May; 6(15):13822-34. PubMed ID: 25360865
[TBL] [Abstract][Full Text] [Related]
10. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Yue J; Zhang C; Shi X; Wei Y; Liu L; Liu S; Yang H
Brain Dev; 2019 Nov; 41(10):829-838. PubMed ID: 31495513
[TBL] [Abstract][Full Text] [Related]
11. T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer.
Fathi M; Pustokhina I; Kuznetsov SV; Khayrullin M; Hojjat-Farsangi M; Karpisheh V; Jalili A; Jadidi-Niaragh F
IUBMB Life; 2021 May; 73(5):726-738. PubMed ID: 33686787
[TBL] [Abstract][Full Text] [Related]
12. Immune inhibitory receptor LILRB2 is critical for the endometrial cancer progression.
Shao H; Ma L; Jin F; Zhou Y; Tao M; Teng Y
Biochem Biophys Res Commun; 2018 Nov; 506(1):243-250. PubMed ID: 30343889
[TBL] [Abstract][Full Text] [Related]
13. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
14. Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2.
Huang J; Burke P; Yang Y; Seiss K; Beamon J; Cung T; Toth I; Pereyra F; Lichterfeld M; Yu XG
J Virol; 2010 Oct; 84(20):10784-91. PubMed ID: 20702625
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development.
Zheng J; Umikawa M; Cui C; Li J; Chen X; Zhang C; Huynh H; Kang X; Silvany R; Wan X; Ye J; Cantó AP; Chen SH; Wang HY; Ward ES; Zhang CC
Nature; 2012 May; 485(7400):656-60. PubMed ID: 22660330
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the expression and prognosis for leukocyte immunoglobulin-like receptor subfamily B in human liver cancer.
Fan J; Wang L; Chen M; Zhang J; Li J; Song F; Gu A; Yin D; Yi Y
World J Surg Oncol; 2022 Mar; 20(1):92. PubMed ID: 35321724
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive molecular biomarkers for the detection of colorectal cancer.
Kim HJ; Yu MH; Kim H; Byun J; Lee C
BMB Rep; 2008 Oct; 41(10):685-92. PubMed ID: 18959813
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of ANGPTL2 and LILRB2 as predictive and therapeutic biomarkers for metastasis and prognosis in colorectal cancer.
He J; Xu J; Yu X; Zhu H; Zeng Y; Fan D; Yi X
Int J Clin Exp Pathol; 2018; 11(5):2281-2294. PubMed ID: 31938340
[TBL] [Abstract][Full Text] [Related]
19. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges.
Das V; Kalita J; Pal M
Biomed Pharmacother; 2017 Mar; 87():8-19. PubMed ID: 28040600
[TBL] [Abstract][Full Text] [Related]
20. Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity.
Chen HM; van der Touw W; Wang YS; Kang K; Mai S; Zhang J; Alsina-Beauchamp D; Duty JA; Mungamuri SK; Zhang B; Moran T; Flavell R; Aaronson S; Hu HM; Arase H; Ramanathan S; Flores R; Pan PY; Chen SH
J Clin Invest; 2018 Dec; 128(12):5647-5662. PubMed ID: 30352428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
